Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amiodarone optic neuropathy--review.

David Chen1, Thomas R Hedges

  • 1Ophthalmology, New England Medical Center, Tufts University, Boston, MA, USA. david8072@yahoo.com

Seminars in Ophthalmology
|October 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of health system interventions to improve access to external beam radiotherapy: a scoping review.

Frontiers in oncology·2026
Same author

Dual tumour-myeloid targeting of glioblastoma with GPNMB CAR-T cells.

Nature·2026
Same author

The optical origin of the human skin color 'banana' in CIELAB space.

bioRxiv : the preprint server for biology·2026
Same author

Treatment times for rural and urban patients with aneurysmal subarachnoid hemorrhage in a provincial hub-and-spoke network.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same author

The Evolving Clinical Utility of Gene Expression Profiling in Cutaneous Melanoma.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Comparison of Corneal Endothelial and Anterior Segment Changes After Nd:YAG Laser Capsulotomy in Eyes with and without Pseudoexfoliation Syndrome.

Seminars in ophthalmology·2026
Same journal

Longitudinal Structural and Functional Trajectories Following Netarsudil Intensification or Surgical Escalation in Primary Open-Angle Glaucoma.

Seminars in ophthalmology·2026
Same journal

Maternal Diabetes Mellitus During Pregnancy as a Risk Factor for Congenital Nasolacrimal Duct Obstruction in the Offspring - a Large-Scale National Study.

Seminars in ophthalmology·2026
Same journal

Clinical Spectrum and Genetics of Ocular Manifestations in Muscle Eye Brain Disease: A Literature Review.

Seminars in ophthalmology·2026
Same journal

Port Delivery System Vs Monthly Ranibizumab in VEGF-Driven Macular Disease: A Systematic Review and Meta-Analysis.

Seminars in ophthalmology·2026
Same journal

Genome Wide Pleiotropic Analysis Reveals Shared Genetic Architecture and Pathological Basis Between Retinitis Pigmentosa and Relevant Ocular Comorbidities.

Seminars in ophthalmology·2026
See all related articles

Amiodarone optic neuropathy presents symptoms similar to non-arteritic anterior ischemic optic neuropathy (AION), complicating diagnosis. This review discusses amiodarone optic neuropathy

Area of Science:

  • Ophthalmology
  • Cardiology
  • Neurology

Background:

  • Amiodarone is an antiarrhythmic drug with known ocular side effects.
  • Optic neuropathy is a potential adverse effect of amiodarone treatment.
  • Clinical presentation of amiodarone optic neuropathy mimics non-arteritic anterior ischemic optic neuropathy (AION).

Purpose of the Study:

  • To discuss the clinical manifestations of amiodarone optic neuropathy.
  • To explore the proposed pathophysiology of amiodarone optic neuropathy.
  • To address the diagnostic challenges and controversy surrounding amiodarone optic neuropathy as a distinct entity.

Main Methods:

  • Literature review of reported cases and existing studies on amiodarone-induced optic neuropathy.
  • Comparative analysis of clinical features between amiodarone optic neuropathy and AION.

Related Experiment Videos

  • Discussion of potential pathomechanisms based on current understanding.

    • Main Results:

    • Amiodarone optic neuropathy shares significant clinical similarities with AION, including visual field defects and optic disc edema.
    • The exact pathophysiology remains unclear, but theories involve mitochondrial dysfunction and axonal transport disruption.
    • Diagnostic differentiation is challenging due to overlapping symptoms and lack of specific biomarkers.

    Conclusions:

    • Amiodarone optic neuropathy is a recognized, albeit controversial, clinical entity.
    • Distinguishing it from AION requires careful patient history, including medication use, and exclusion of other causes.
    • Further research is needed to elucidate the precise mechanisms and establish definitive diagnostic criteria.